Datasets
Buyer room
BIOPHARMAWATCH.COMManage supplier listing
BiopharmaWatch — Institutional-grade biotech investment data API covering FDA/PDUFA catalysts, clinical trial pipelines, SEC-filing-derived financial health signals (cash runway, burn, dilution), hedge-fund 13F/insider 'Smart Money' positioning, and options analytics across 1,100+ biotech/pharma companies — aggregated from public filings/registries into a proprietary structured dataset. Early-stage niche biotech data/analytics subscription business (1-10 employees, founded 2023, ~€20K disclosed funding, ~173 LinkedIn followers). Use cases: Quant trading models, biotech-focused hedge fund and …
supplier index read from their site
Institutional-grade biotech investment data API covering FDA/PDUFA catalysts, clinical trial pipelines, SEC-filing-derived financial health signals (cash runway, burn, dilution), hedge-fund 13F/insider 'Smart Money' positioning, and options analytics across 1,100+ biotech/pharma companies — aggregated from public filings/registries into a proprietary structured dataset
Scale 11From 5 yearsCoverage Health Care · Financials
Sample, licence terms, pricing and eval results when BiopharmaWatch publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about BiopharmaWatch, answered from this page.
BiopharmaWatch — Institutional-grade biotech investment data API covering FDA/PDUFA catalysts, clinical trial pipelines, SEC-filing-derived financial health signals (cash runway, burn, dilution), hedge-fund 13F/insider 'Smart Money' positioning, and options analytics across 1,100+ biotech/pharma companies — aggregated from public filings/registries into a proprietary structured dataset. Early-stage niche biotech data/analytics subscription business (1-10 employees, founded 2023, ~€20K disclosed funding, ~173 LinkedIn followers). Use cases: Quant trading models, biotech-focused hedge fund and …
BiopharmaWatch offers (Alternative, Fundamental, Sentiment) — 11,000+ upcoming catalysts and 83,000+ tracked clinical trials across 1,100+ biotech/pharma companies, plus 5+ years of historical PDUFA outcome data (stated coverage metrics on site).
Quant trading models, biotech-focused hedge fund and retail research, screening/backtesting tools, AI-assistant integrations (MCP connector for ChatGPT/Claude/Cursor) for biotech due-diligence copilots
The data is with 5 years of history.
Coverage spans US; Biotechnology, Financial Exchanges & Data; alternative, fundamental, sentiment; equities, options.
The supplier's own access route is a conversation with the supplier. Request a sample through Brickroad to start.
BiopharmaWatch has not added their own details yet. Not yet on file: